Revision as of 02:53, 4 March 2007 editFvasconcellos (talk | contribs)Autopatrolled, Administrators30,939 edits added SVG structure, Template:NSAIDs← Previous edit | Revision as of 13:10, 28 June 2007 edit undoOmulazimoglu (talk | contribs)604 editsNo edit summaryNext edit → | ||
Line 29: | Line 29: | ||
{{Pharma-stub}} | {{Pharma-stub}} | ||
] |
Revision as of 13:10, 28 June 2007
Pharmaceutical compoundClinical data | |
---|---|
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 100% |
Elimination half-life | 7.3 ± 4.0 hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.157.848 |
Chemical and physical data | |
Formula | C17H21NO3 |
Molar mass | 287.354 g/mol g·mol |
Etodolac is the International Nonproprietary Name (INN) of 1,8-diethyl-1,3,4,9-tetrahydropyrano-indole-1-acetic acid (empirical formula C17H21NO3), also sold under the trade name Lodine. It is a non-steroidal anti-inflammatory drug (NSAID). It is used to treat pain associated with arthritis and other conditions.
External links
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |
- "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.